Based on these criteria, we identified nonsynonymous coding variants in several genes associated with chromatin structure modification and epigenetic regulation (TET2, DNMT3A, KMT2C, KMT2D, SETD2, CREBBP), tumor suppression (FAT1, LATS1, STK3, TP53, TP63, ATM), and NOTCH signaling (NOTCH1, NOTCH2) (Fig. 1c). The gene discussed is SETD2; the disease is neoplasm.